These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 21939467)

  • 21. Long-term outcome of subthalamic nucleus deep brain stimulation for Parkinson's disease using an MRI-guided and MRI-verified approach.
    Aviles-Olmos I; Kefalopoulou Z; Tripoliti E; Candelario J; Akram H; Martinez-Torres I; Jahanshahi M; Foltynie T; Hariz M; Zrinzo L; Limousin P
    J Neurol Neurosurg Psychiatry; 2014 Dec; 85(12):1419-25. PubMed ID: 24790212
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacies of globus pallidus stimulation and subthalamic nucleus stimulation for advanced Parkinson's disease: a meta-analysis of randomized controlled trials.
    Tan ZG; Zhou Q; Huang T; Jiang Y
    Clin Interv Aging; 2016; 11():777-86. PubMed ID: 27382262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subthalamic Nucleus Deep Brain Stimulation May Reduce Medication Costs in Early Stage Parkinson's Disease.
    Hacker ML; Currie AD; Molinari AL; Turchan M; Millan SM; Heusinkveld LE; Roach J; Konrad PE; Davis TL; Neimat JS; Phibbs FT; Hedera P; Byrne DW; Charles D
    J Parkinsons Dis; 2016; 6(1):125-31. PubMed ID: 26967937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guideline on Subthalamic Nucleus and Globus Pallidus Internus Deep Brain Stimulation for the Treatment of Patients With Parkinson's Disease: Executive Summary.
    Rughani A; Schwalb JM; Sidiropoulos C; Pilitsis J; Ramirez-Zamora A; Sweet JA; Mittal S; Espay AJ; Martinez JG; Abosch A; Eskandar E; Gross R; Alterman R; Hamani C
    Neurosurgery; 2018 Jun; 82(6):753-756. PubMed ID: 29538685
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deep brain stimulation of the subthalamic nucleus for advanced Parkinson disease using general anesthesia: long-term results.
    Harries AM; Kausar J; Roberts SA; Mocroft AP; Hodson JA; Pall HS; Mitchell RD
    J Neurosurg; 2012 Jan; 116(1):107-13. PubMed ID: 21999316
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term Efficacy of Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease: A 5-year Follow-up Study in China.
    Jiang LL; Liu JL; Fu XL; Xian WB; Gu J; Liu YM; Ye J; Chen J; Qian H; Xu SH; Pei Z; Chen L
    Chin Med J (Engl); 2015 Sep; 128(18):2433-8. PubMed ID: 26365958
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Different effectiveness of subthalamic deep brain stimulation in Parkinson's disease: A comparative cohort study at 1 year and 5 years.
    Jiang JL; Chen SY; Hsieh TC; Lee CW; Lin SH; Tsai ST
    J Formos Med Assoc; 2015 Sep; 114(9):835-41. PubMed ID: 24103710
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early subthalamic nucleus deep brain stimulation in Parkinson's disease reduces long-term medication costs.
    Hacker M; Cannard G; Turchan M; Meystedt J; Davis T; Phibbs F; Hedera P; Konrad P; Charles D
    Clin Neurol Neurosurg; 2021 Nov; 210():106976. PubMed ID: 34666273
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of bilateral subthalamic stimulation on motor/cognitive functions in Parkinson's disease.
    Asahi T; Nakamichi N; Takaiwa A; Kashiwazaki D; Koh M; Dougu N; Takashima S; Tanaka K; Kuroda S
    Neurol Med Chir (Tokyo); 2014; 54(7):529-36. PubMed ID: 24872253
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deep brain stimulation for Parkinson's disease: meta-analysis of results of randomized trials at varying lengths of follow-up.
    Mansouri A; Taslimi S; Badhiwala JH; Witiw CD; Nassiri F; Odekerken VJJ; De Bie RMA; Kalia SK; Hodaie M; Munhoz RP; Fasano A; Lozano AM
    J Neurosurg; 2018 Apr; 128(4):1199-1213. PubMed ID: 28665252
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease.
    Moro E; Lozano AM; Pollak P; Agid Y; Rehncrona S; Volkmann J; Kulisevsky J; Obeso JA; Albanese A; Hariz MI; Quinn NP; Speelman JD; Benabid AL; Fraix V; Mendes A; Welter ML; Houeto JL; Cornu P; Dormont D; Tornqvist AL; Ekberg R; Schnitzler A; Timmermann L; Wojtecki L; Gironell A; Rodriguez-Oroz MC; Guridi J; Bentivoglio AR; Contarino MF; Romito L; Scerrati M; Janssens M; Lang AE
    Mov Disord; 2010 Apr; 25(5):578-86. PubMed ID: 20213817
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term impact on quality of life of subthalamic nucleus stimulation in Parkinson's disease.
    Lezcano E; Gómez-Esteban JC; Tijero B; Bilbao G; Lambarri I; Rodriguez O; Villoria R; Dolado A; Berganzo K; Molano A; de Gopegui ER; Pomposo I; Gabilondo I; Zarranz JJ
    J Neurol; 2016 May; 263(5):895-905. PubMed ID: 26964542
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of indirect and direct targeted STN DBS in the treatment of Parkinson's disease-surgical method and clinical outcome over 15-year timespan.
    Lahtinen MJ; Haapaniemi TH; Kauppinen MT; Salokorpi N; Heikkinen ER; Katisko JP
    Acta Neurochir (Wien); 2020 May; 162(5):1067-1076. PubMed ID: 32103343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination targeting of subthalamic nucleus and ventral intermediate thalamic nucleus with a single trajectory in deep brain stimulation for tremor-dominant Parkinson's disease.
    Fayed I; Cobourn KD; Pivazyan G; Torres-Yaghi YA; Pagan FL; Lo SE; Mandir AS; Kalhorn CG
    J Clin Neurosci; 2021 Mar; 85():92-100. PubMed ID: 33581797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Eight-year follow-up outcome of subthalamic deep brain stimulation for Parkinson's disease: Maintenance of therapeutic efficacy with a relatively low levodopa dosage and stimulation intensity.
    Jiang L; Chen W; Guo Q; Yang C; Gu J; Xian W; Liu Y; Zheng Y; Ye J; Xu S; Hu Y; Wu L; Chen J; Qian H; Fu X; Liu J; Chen L
    CNS Neurosci Ther; 2021 Nov; 27(11):1366-1373. PubMed ID: 34350691
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of deep brain stimulation of the subthalamic nucleus on freezing of gait in Parkinson's disease: a prospective controlled study.
    Vercruysse S; Vandenberghe W; Münks L; Nuttin B; Devos H; Nieuwboer A
    J Neurol Neurosurg Psychiatry; 2014 Aug; 85(8):871-7. PubMed ID: 24396010
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bilateral subthalamic nucleus stimulation in the treatment of advanced Parkinson's disease. Five years' personal experience.
    Zabek M; Sobstyl M; Koziara H; Kadziołka B; Mossakowski Z; Dzierzecki S
    Neurol Neurochir Pol; 2010; 44(1):3-12. PubMed ID: 20358480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deep brain stimulation of the subthalamic nucleus in Parkinson's disease patients over 75 years of age.
    Sharma VD; Lyons KE; Nazzaro JM; Pahwa R
    J Neurol Sci; 2019 Apr; 399():57-60. PubMed ID: 30772762
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up.
    Rodriguez-Oroz MC; Obeso JA; Lang AE; Houeto JL; Pollak P; Rehncrona S; Kulisevsky J; Albanese A; Volkmann J; Hariz MI; Quinn NP; Speelman JD; Guridi J; Zamarbide I; Gironell A; Molet J; Pascual-Sedano B; Pidoux B; Bonnet AM; Agid Y; Xie J; Benabid AL; Lozano AM; Saint-Cyr J; Romito L; Contarino MF; Scerrati M; Fraix V; Van Blercom N
    Brain; 2005 Oct; 128(Pt 10):2240-9. PubMed ID: 15975946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deep brain stimulation may reduce the relative risk of clinically important worsening in early stage Parkinson's disease.
    Hacker ML; Tonascia J; Turchan M; Currie A; Heusinkveld L; Konrad PE; Davis TL; Neimat JS; Phibbs FT; Hedera P; Wang L; Shi Y; Shade DM; Sternberg AL; Drye LT; Charles D
    Parkinsonism Relat Disord; 2015 Oct; 21(10):1177-83. PubMed ID: 26306000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.